{"document_text": "REFERRAL LETTER - Date: 2024-11-15. To: Dr. Karen Mitchell, Pulmonology. From: Dr. Brian Cooper, Family Medicine. Re: Patricia A. Lawson, DOB: 1958-04-30, MRN: 2247891. Dear Dr. Mitchell, I am referring Mrs. Lawson for evaluation of persistent dyspnea on exertion over the past 4 months. She is a 66-year-old former smoker (35 pack-year history, quit 2019) with a history of mild COPD. Recent spirometry shows FEV1 58% predicted, FEV1/FVC ratio 0.62, consistent with moderate obstruction. Despite compliance with tiotropium and albuterol PRN, she reports progressive limitation in her daily activities. Current medications: Tiotropium 18 mcg inhaled daily, albuterol MDI PRN, amlodipine 5 mg daily. Please advise on further workup and management optimization.", "extracted": {"patient_name": "Patricia A. Lawson", "date_of_birth": "1958-04-30", "referring_physician": "Dr. Brian Cooper, Family Medicine", "reason_for_referral": "Persistent dyspnea on exertion with moderate COPD", "spirometry_results": "FEV1 58% predicted, FEV1/FVC 0.62", "smoking_history": "Former smoker, 35 pack-years, quit 2019"}}
{"document_text": "EMERGENCY DEPARTMENT NOTE - Date: 2024-12-01, Time: 2315. Patient: Thomas G. Wright, DOB: 1991-07-12, MRN: 5578234. Triage Category: ESI Level 2. Chief Complaint: Severe allergic reaction. HPI: 33-year-old male brought in by EMS after developing diffuse urticaria, tongue swelling, and respiratory distress approximately 20 minutes after eating shrimp at a restaurant. Patient has a known shellfish allergy but states the dish was not supposed to contain shellfish. On arrival: BP 88/52, HR 122, RR 28, SpO2 91% on room air. Treatment: Epinephrine 0.3 mg IM administered by EMS en route, repeated in ED. IV normal saline 1L bolus, diphenhydramine 50 mg IV, methylprednisolone 125 mg IV, famotidine 20 mg IV. Patient stabilized with BP 110/72, HR 92, SpO2 98% on 2L NC after 45 minutes. Disposition: Admitted for 24-hour observation given biphasic reaction risk.", "extracted": {"patient_name": "Thomas G. Wright", "date_of_birth": "1991-07-12", "chief_complaint": "Severe allergic reaction (anaphylaxis) to shellfish", "triage_level": "ESI Level 2", "treatments_administered": ["Epinephrine 0.3 mg IM x2", "IV normal saline 1L bolus", "Diphenhydramine 50 mg IV", "Methylprednisolone 125 mg IV", "Famotidine 20 mg IV"], "disposition": "Admitted for 24-hour observation"}}
{"document_text": "PHYSICAL THERAPY EVALUATION - Date: 2024-10-28. Patient: Linda S. Yamamoto, DOB: 1950-12-03, MRN: 6623451. Referring Physician: Dr. James Wilson, Orthopedic Surgery. Diagnosis: Status post left total hip arthroplasty (POD #2). Subjective: Patient reports pain 5/10 at surgical site, controlled with current medications. Denies numbness or tingling in the left lower extremity. Objective: Left hip ROM: Flexion 75 degrees, abduction 20 degrees, extension 0 degrees (hip precautions observed). Strength: Left hip flexors 3/5, abductors 3-/5, knee extensors 3+/5. Gait: Ambulated 50 feet with rolling walker, moderate assistance x1, antalgic gait pattern. Transfers: Bed to chair with moderate assistance, posterior hip precautions maintained. Assessment: Patient is making expected progress for POD #2. Functional mobility is limited but improving. Goals: Independent ambulation with walker 150 feet by discharge (estimated POD #4).", "extracted": {"patient_name": "Linda S. Yamamoto", "date_of_birth": "1950-12-03", "diagnosis": "Status post left total hip arthroplasty, POD #2", "hip_flexion_rom": "75 degrees", "ambulation_status": "50 feet with rolling walker, moderate assistance x1", "discharge_goal": "Independent ambulation with walker 150 feet by POD #4"}}
{"document_text": "IMMUNIZATION RECORD - Date: 2024-09-10. Patient: Emily R. Jackson, DOB: 2024-03-15, MRN: 8834521. Pediatrician: Dr. Natalie Brooks, MD. Visit Type: 6-month well-child visit. Vaccines Administered: DTaP (Daptacel, Lot# AC52B017A, exp 2025-06, right vastus lateralis), IPV (IPOL, Lot# P7544A, exp 2025-03, left vastus lateralis), Hep B #3 (Engerix-B, Lot# AHBVB831BA, exp 2025-08, right vastus lateralis), PCV15 (Vaxneuvance, Lot# T004781, exp 2025-05, left vastus lateralis). Influenza vaccine deferred per parental request, discussed risks and benefits, will revisit at 9-month visit. VIS provided for all administered vaccines. No adverse reactions during 15-minute observation period. Weight: 7.8 kg (60th percentile), Length: 66 cm (50th percentile), Head circumference: 43.5 cm (65th percentile). Next visit: 9 months.", "extracted": {"patient_name": "Emily R. Jackson", "date_of_birth": "2024-03-15", "visit_type": "6-month well-child visit", "vaccines_given": ["DTaP (Daptacel)", "IPV (IPOL)", "Hepatitis B #3 (Engerix-B)", "PCV15 (Vaxneuvance)"], "vaccines_deferred": "Influenza (parental request)", "weight": "7.8 kg (60th percentile)"}}
